因此，武田、阿斯特拉和第一三共制药都预期到今年药品的营业利润会骤降。

As a result, Takeda, Astellas and Daiichi Sankyo all expect a steep drop in operating profits this year.

youdao

因此，武田、阿斯特拉和第一三共制药都预期到今年药品的营业利润会骤降。

As a result, Takeda, Astellas and Daiichi Sankyo all expect a steep drop in operating profits this year.

youdao